2020
DOI: 10.1007/978-3-030-44921-6_5
|View full text |Cite
|
Sign up to set email alerts
|

Vesicular Nanocarriers: A Potential Platform for Dermal and Transdermal Drug Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 321 publications
1
6
0
Order By: Relevance
“…The droplet size of the nanoemulsion is typically in the range 20 to 300 nm for an optimized penetration with topical application. The results of the optimized formula showed a globule size of 245 nm which was in agreement with previously published data which indicated that, the globular size for any transdermal and topically applied vesicular drug delivery system is preferred to be less than 300 nm in order to penetrate easily through skin layers [ 42 , 43 ].…”
Section: Resultssupporting
confidence: 89%
See 1 more Smart Citation
“…The droplet size of the nanoemulsion is typically in the range 20 to 300 nm for an optimized penetration with topical application. The results of the optimized formula showed a globule size of 245 nm which was in agreement with previously published data which indicated that, the globular size for any transdermal and topically applied vesicular drug delivery system is preferred to be less than 300 nm in order to penetrate easily through skin layers [ 42 , 43 ].…”
Section: Resultssupporting
confidence: 89%
“…The above results showed a higher significant effect of the rosehip oil concentration compared with the other variables. This was due to the antimicrobial properties of the rosehip oil [ 41 , 42 ].…”
Section: Resultsmentioning
confidence: 99%
“…For instance, a clove oil-based NE was developed to combine the anti-inflammatory and antifungal properties of the main oil component, eugenol, with those of the drug cargo, naftifine, used to tackle skin fungal infections [ 39 ]. Lately, other types of liposome-inspired vesicles ( Figure 5 ), such as ethosomes, transfersomes, niosomes, among other, have been advanced [ 1 , 3 , 40 , 41 ]. Lipid-based/inspired nanosystems stem from ancient knowledge on the value of fatty acids and derived hydrolyzable lipids, especially phospholipids, to enhance percutaneous absorption of a variety of substances for both health- and beauty-care.…”
Section: Overview Of Current Methods For Dermal and Transdermal Drug Deliverymentioning
confidence: 99%
“…Lipid-based/inspired nanosystems stem from ancient knowledge on the value of fatty acids and derived hydrolyzable lipids, especially phospholipids, to enhance percutaneous absorption of a variety of substances for both health- and beauty-care. Phospholipid-based emulsions, as well as micellar and liposomal formulations for skin care are all around us, hence it comes as no surprise that lipid-based/inspired nanocarriers have a prominent role in current approaches for DTD of [bio]pharmaceuticals [ 1 , 3 , 40 , 41 , 42 , 43 ]. Still, nanosystems that do not [exclusively] derive from natural lipids have been thoroughly explored for percutaneous permeation of bioactive molecules; organic nanoformulations comprising either natural or synthetic polymers and/or surfactants other than natural lipids can be found in recent literature, covering distinct types of dendrimers, nanoparticles (NPs), nanoemulsions (NEs), micelles, and hydrogels, for diverse purposes.…”
Section: Overview Of Current Methods For Dermal and Transdermal Drug Deliverymentioning
confidence: 99%
“…Propylene glycol, water, ethanol, transcutol P, caprylic acid, and isopropyl alcohol are some of the solvents that can increase drug permeation through a number of different mechanisms, including the disruption of intercellular lipid structures, fluidization of stratum corneum (SC) lipids, modification of cellular proteins, and extraction of intercellular lipids. Polar solvents, such as dimethyl sulfoxide (DMSO) and dimethyl form amide, were shown to enhance the stratum corneum's diffusely (DMFA) (10,11). Minoxidil is the most common drug used to treat hair loss, which is available as a generic medication over-the-counter for treating androgenic alopecia and, a form of hair loss in people with a molecular weight of 209.253 g/mol.…”
Section: Introductionmentioning
confidence: 99%